sk&f 107260 has been researched along with acetyl-arginyl-glycyl-aspartyl-serinamide in 1 studies
Studies (sk&f 107260) | Trials (sk&f 107260) | Recent Studies (post-2010) (sk&f 107260) | Studies (acetyl-arginyl-glycyl-aspartyl-serinamide) | Trials (acetyl-arginyl-glycyl-aspartyl-serinamide) | Recent Studies (post-2010) (acetyl-arginyl-glycyl-aspartyl-serinamide) |
---|---|---|---|---|---|
11 | 0 | 0 | 5 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bean, JW; Burgess, JL; Callahan, JF; Eggleston, DS; Hwang, SM; Kopple, KD; Koster, PF; Nichols, A; Peishoff, CE; Samanen, JM | 1 |
1 other study(ies) available for sk&f 107260 and acetyl-arginyl-glycyl-aspartyl-serinamide
Article | Year |
---|---|
Design and synthesis of a C7 mimetic for the predicted gamma-turn conformation found in several constrained RGD antagonists.
Topics: Amino Acid Sequence; Drug Design; Fibrinogen; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Conformation | 1992 |